BFM
CPRX

Boothbay Fund Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Boothbay Fund Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,733
Closed -$204K – 2133
2025
Q4 		$204K Sell
8,733
-11,683
-57% -$260K ﹤0.01% 1654
2025
Q3 		$402K Sell
20,416
-20,175
-50% -$415K 0.01% 1290
2025
Q2 		$881K Sell
40,591
-14,292
-26% -$337K 0.02% 725
2025
Q1 		$1.33M Sell
54,883
-21,982
-29% -$495K 0.04% 537
2024
Q4 		$1.6M Sell
76,865
-29,362
-28% -$631K 0.04% 497
2024
Q3 		$2.11M Sell
106,227
-14,623
-12% -$271K 0.05% 499
2024
Q2 		$1.87M Hold
120,850
– – 0.04% 521
2024
Q1 		$1.93M Buy
120,850
+12,524
+12% +$189K 0.04% 522
2023
Q4 		$1.82M Hold
108,326
– – 0.05% 527
2023
Q3 		$1.27M Buy
+108,326
New +$1.45M 0.03% 662
2018
Q4 		– Sell
-100,181
Closed -$379K – 697
2018
Q3 		$379K Buy
100,181
+16,000
+19% +$50.1K 0.04% 446
2018
Q2 		$263K Sell
84,181
-38,819
-32% -$118K 0.02% 522
2018
Q1 		$294K Buy
+123,000
New +$409K 0.03% 476
2017
Q3 		– Sell
-68,970
Closed -$190K – 622
2017
Q2 		$190K Sell
68,970
-66,902
-49% -$140K 0.04% 572
2017
Q1 		$265K Buy
+135,872
New +$173K 0.05% 476
2016
Q1 		– Sell
-39,695
Closed -$97K – 364
2015
Q4 		$97K Sell
39,695
-23,972
-38% -$68.7K 0.04% 507
2015
Q3 		$191K Buy
+63,667
New +$275K 0.09% 333

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boothbay Fund Management's CPRX Position: Q1 2026 in Review

Boothbay Fund Management sold out of Catalyst Pharmaceutical (CPRX) in Q1 2026, closing a stake of 8,733 shares — an estimated $204K sold.

Boothbay Fund Management first reported a position in CPRX in Q3 2015 and held it in 17 quarters. The position peaked at $2.11M in Q3 2024. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Boothbay Fund Management reported no remaining Catalyst Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 8,733 Catalyst Pharmaceutical shares in Q1 2026, an estimated $204K.
  • Boothbay Fund Management first reported a position in Catalyst Pharmaceutical in Q3 2015 and held it in 17 quarters.
  • Boothbay Fund Management's Catalyst Pharmaceutical position peaked at $2.11M in Q3 2024.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.